Gelucire 50 13
Gelucire 50/13 is a semi-synthetic excipient composed of glycerides and polyethylene glycol esters. It has a melting range of 50-55°C and an HLB value of 13, making it suitable for use in pharmaceutical and cosmetic formulations.
Lab products found in correlation
12 protocols using gelucire 50 13
Dutasteride Solubility Enhancement with Cyclodextrins
Ibuprofen Lipid-Based Formulation Development
Lipid-based Ophthalmic Drug Delivery
Luliconazole Topical Formulation Development
Development and Evaluation of Xarelto Formulations
Polyvinylpyrrolidone-vinyl acetate 64 (PVP VA 64, Kollidone® VA 64), Soluplus® (Polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft co-polymer), Cremophor® RH 40 (PEG-40 hydrogenated castor oil), polyvinylpyrrolidone K 90 (PVP 90), Solutol® HS 15 (Polyoxyl 15-hydroxystearate), and Kolliphor® 188 (Poloxamer 188) were obtained from BASF (Ludwigshafen, Germany). Polyvinylalcohol (PVA, MW 89,000–98,000) was purchased from Sigma (St. Louis, MO, USA), and polyethylene glycol (PEG) was purchased from Daejung (Seoul, Korea). Gelucire® 44/14 (Lauroyl polyoxy-32-glycerides) and Gelucire® 50/13 (Stearoyl macrogol-32 glycrides) were obtained from Gattefosse (Saint-Priest, France). Carboxymethyl cellulose (CMC) and hydroxypropyl cellulose (HPC) were purchased from Samchun (Pyeongtaek, Korea). Acetonitrile and methanol for HPLC were purchased from J.T. Baker (Seoul, Korea). All the other chemicals and reagents used were of analytical grade.
Cellular Uptake of Protocatechuic Acid Ester
The chemical 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT), Dulbecco’s modified Eagle’s medium, fetal bovine serum, glucose, and penicillin–streptomycin, were obtained from Sigma Aldrich (Milan, Italy).
Human foreskin fibroblast (HFF-1) and human colorectal adenocarcinoma (CaCo-2) cells were bought from ATCC® SCRC-1041 TM (ATCC, Manassas, VA, USA). Purified water from Millipore-Q® Gradient A10TM ultra-pure water system (Millipore, Guyancourt, France) was produced as needed and employed for the duration of the studies.
Lipid-based Nanoparticle Formulation Development
Formulation Development of Ramipril
Lipid Nanosuspension for Dexamethasone Delivery
Two different sizes of DxPCA loaded NLP were produced to study the effect of loading. Furthermore, DxPCA was incorporated into single lipid components of the NLP and in selected lipid combinations, with and without dispersion in water to associate the microenvironment of DxPCA in the NLP.
Mucoadhesive Nanoparticle Formulation Development
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!